Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Raises Dividend to $0.87 Per Share

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) declared an annual dividend on Friday, May 1st. Investors of record on Friday, May 22nd will be paid a dividend of 0.8716 per share on Monday, June 8th. This represents a yield of 385.0%. The ex-dividend date of this dividend is Friday, May 22nd. This is a 10.7% increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79.

Fresenius Medical Care AG & Co. KGaA has raised its dividend payment by an average of 0.0%per year over the last three years. Fresenius Medical Care AG & Co. KGaA has a dividend payout ratio of 25.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Fresenius Medical Care AG & Co. KGaA to earn $2.43 per share next year, which means the company should continue to be able to cover its $0.61 annual dividend with an expected future payout ratio of 25.1%.

Fresenius Medical Care AG & Co. KGaA Stock Down 0.4%

Shares of FMS stock opened at $22.12 on Wednesday. The stock has a market cap of $12.36 billion, a P/E ratio of 11.64, a price-to-earnings-growth ratio of 4.01 and a beta of 0.81. The stock has a fifty day moving average price of $22.47 and a 200 day moving average price of $23.14. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $30.46. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.20 and a quick ratio of 0.86.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share for the quarter. The business had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. Analysts predict that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.